Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medici

Editors’ Note: In WriteClick this week, Haliloglu and Topaloglu comment on “Evidence-based guideline summary: Evaluation, diagnosis, and management of congenital muscular dystrophy,” and authors Kang et al. answer their points, noting that the guideline generally based its statements on the articles with the best methodology. Dr. Bronstein challenges the conclusion in “Neuropsychological outcome after deep brain stimulation for Parkinson disease” that the subthalamic nucleus is the preferred target in deep brain stimulation over the globus pallidus pars interna. Authors Odekerken et al. summarize their supporting data. It is clear that the matter may not yet be settled. —Megan Alcauskas, MD, and Robert C. Griggs, MD

[1]  Ching H. Wang,et al.  Diagnostic approach to the congenital muscular dystrophies , 2014, Neuromuscular Disorders.

[2]  I. Nishino,et al.  Megaconial congenital muscular dystrophy due to loss-of-function mutations in choline kinase &bgr; , 2013, Current opinion in neurology.

[3]  F. Lamari,et al.  Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases , 2013, Journal of Inherited Metabolic Disease.

[4]  L. Kunkel,et al.  Mutations in the satellite cell gene MEGF10 cause a recessive congenital myopathy with minicores , 2012, neurogenetics.

[5]  I. Nonaka,et al.  A congenital muscular dystrophy with mitochondrial structural abnormalities caused by defective de novo phosphatidylcholine biosynthesis. , 2011, American journal of human genetics.

[6]  N. Bresolin,et al.  New molecular findings in congenital myopathies due to selenoprotein N gene mutations , 2011, Journal of the Neurological Sciences.

[7]  G. Vasco,et al.  Congenital muscular dystrophies with cognitive impairment , 2010, Neurology.

[8]  Susan C. Brown,et al.  A comparative analysis of collagen VI production in muscle, skin and fibroblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COL6A mutations , 2006, Neuromuscular Disorders.

[9]  F. Muntoni,et al.  Prenatal diagnosis in laminin α2 chain (merosin)-deficient congenital muscular dystrophy: A collective experience of five international centers , 2005, Neuromuscular Disorders.

[10]  H. Topaloglu,et al.  An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker–Warburg syndrome (WWS) caused by a mutation in the POMT1 gene , 2005, Neuromuscular Disorders.